Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- Check6 days agoChange DetectedThe revision tag on the page updates to Revision: v3.7.0, replacing Revision: v3.6.6. This reflects an update to the page's revision history/backend rather than a change to the study information shown.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision tag changed from v3.6.5 to v3.6.6, signaling a new page revision. This is a minor maintenance update and does not reflect changes to the study content.SummaryDifference0.1%

- Check28 days agoChange DetectedAn NIH funding reference for 2017 was added to the study's identifier section, reflecting the funding source associated with the trial. This is an administrative detail that does not alter the study design, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, signaling a new minor update to the page. This reflects a metadata or formatting adjustment rather than changes to study details.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling an administrative update to the record. No study details or data appear to be affected by this change.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page template and does not affect study content.SummaryDifference0.1%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.